Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion

International Journal of Hematology

Volumn 99, Issue 1, 2014, Pages 21-31

  Shima, Haruko ^a,b   Yamagata, Kazutsune ^a   Aikawa, Yukiko ^a   Shino, Mika ^a   Koseki, Haruhiko ^c   Shimada, Hiroyuki ^b   Kitabayashi, Issay ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Institute of Physical and Chemical Research   (Japan)

Author keywords

AML; BRPF1; HOX genes; MOZ TIF2

Indexed keywords

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HISTONE ACETYLTRANSFERASES; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS;

EID: 84899095665     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-013-1466-x     Document Type: Article

References (27)

1. Kitabayashi I, Aikawa Y, Nguyen LA, et al. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J. 2001;20(24):7184-96. (Pubitemid 34062310)
2. Aikawa Y, Katsumoto T, Zhang P, et al. PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2. Nat Med. 2010;16(5):580-5.
3. Rokudai S, Aikawa Y, Tagata Y, et al. Monocytic leukemia zinc finger (MOZ) interacts with p53 to induce p21 expression and cell-cycle arrest. J Biol Chem. 2009;284(1):237-44.
4. Katsumoto T, Aikawa Y, Iwama A, et al. MOZ is essential for maintenance of hematopoietic stem cells. Genes Dev. 2006;20(10):1321-30. (Pubitemid 43727592)
5. Borrow J, Stanton VP Jr, Andresen JM, et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet. 1996;14:33-41.
6. Kitabayashi I, Aikawa Y, Yokoyama A, et al. Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation. Leukemia. 2001;15:89-94. (Pubitemid 32124073)
7. Chaffanet M, Gressin L, Preudhomme C, et al. MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer. 2000;28:138-44. (Pubitemid 30246991)
8. Deguchi K, Ayton PM, Carapeti M, et al. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell. 2003;3:259-71. (Pubitemid 37443881)
9. Yang XJ, Ullah M. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells. Oncogene. 2007;26:5408-19. (Pubitemid 47255923)
10. Carapeti M, Aguiar RC, Goldman JM, et al. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood. 1998;91:3127-33. (Pubitemid 28193860)
11. Calvo KR, Sykes DB, Pasillas M, Kamps MP. Hoxa9 immortalizes a granulocyte macrophage colony stimulating factor dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages independent of enforced Meis expression. Mol Cell Biol. 2000;20:3274-85. (Pubitemid 30215039)
12. Buske C, Feuring-Buske M, Antonchuk J, et al. Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo. Blood. 2001;97:2286-92. (Pubitemid 32291473)
13. Thorsteinsdottir U, Mamo A, Kroon E, et al. Overexpression of the myeloid leukemia associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood. 2002;99:121-9.
14. Thorsteinsdottir U, Sauvageau G, Hough MR, et al. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol. 1997;17:495-505. (Pubitemid 26425639)
15. Camós M, Esteve J, Jares P, et al. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression. Cancer Res. 2006;66(14):6947-54. (Pubitemid 44197669)
16. Hibiya K, Katsumoto T, Kondo T, et al. Brpf1, a subunit of the MOZ histone acetyl transferase complex, maintains expression of anterior and posterior Hox genes for proper patterning of craniofacial and caudal skeletons. Dev Biol. 2009;329(2):176-90.
17. Laue K, Daujat S, Crump JG, et al. The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity. Development. 2008;135:1935-46. (Pubitemid 351943358)
18. Ullah M, Pelletier N, Xiao L, et al. Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes. Mol Cell Biol. 2008;28(22):6828-43.
19. Ikura T, Ogryzko VV, Grigoriev M, et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell. 2000;102(4):463-73.
20. Perez-Campo FM, Borrow J, Kouskoff V, Lacaud G. The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors. Blood. 2009;113(20):4866-74.
21. Thorsteinsdottir U, Kroon E, Jerome L, et al. Defining roles of Hox and MEIS1 genes in induction of acute myeloid leukemia. Mol Cell Biol. 2001;21(1):224-34.
22. Kroon E, Krosl J, Thorsteinsdottir U, et al. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 1998;17(13):3714-25. (Pubitemid 28327389)
23. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531-7.
24. Andreeff M, Ruvolo V, Gadgil S, et al. HOX expression patterns identify a common signature for favorable AML. Leukemia. 2008;22(11):2041-7.
25. Vezzoli A, Bonadies N, Allen MD, et al. Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. Nat Struct Mol Biol. 2010;17(5):617-9.
26. Naoe T, Kiyoi H. Gene mutations of acute myeloid leukemia in the genome era. Int J Hematol. 2013;97(2):165-74.
27. Shima Y, Kitabayashi I. Deregulated transcription factors in leukemia. Int J Hematol. 2011;94(2):134-41.